Voya Investment Management LLC Galectin Therapeutics Inc Transaction History

Voya Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.07 - $5.1 $39,180 - $96,532	-18,928 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.24 - $2.87 $11,892 - $15,236	5,309 Added 38.98%	18,928 $42,000
Q2 2020 Aug 14, 2020	SELL	$1.66 - $3.15 $15,529 - $29,468	-9,355 Reduced 40.72%	13,619 $42,000
Q4 2019 Feb 14, 2020	BUY	$2.79 - $4.32 $21,753 - $33,683	7,797 Added 51.37%	22,974 $66,000
Q2 2019 Aug 14, 2019	BUY	$3.61 - $5.0 $54,788 - $75,885	15,177 New	15,177 $63,000

9.69M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $73.7M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.